Dr. Eunice Wang Discusses Newly Approved Treatments for Acute Myeloid Leukemia
source: pixabay.com

Dr. Eunice Wang Discusses Newly Approved Treatments for Acute Myeloid Leukemia

  Earlier this year, The Leukemia & Lymphoma Society hosted a presentation by Dr. Eunice Wang, Clinical Leukemia Service, Professor of Oncology, Roswell Park Comprehensive Cancer Center. Dr. Wang’s presentation…

Continue Reading Dr. Eunice Wang Discusses Newly Approved Treatments for Acute Myeloid Leukemia
Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
source: pixabay.com

Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know

According to a story from LocalHealthGuide, COVID-19 has continued to spread through the US and the lackluster government response suggests that it isn't going to be contained any time soon.…

Continue Reading Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
Study Assesses Rare Disease Treatments for Children From 2010-2018
source: pixabay.com

Study Assesses Rare Disease Treatments for Children From 2010-2018

According to a story from Charcot-Marie-Tooth News, a new study highlights the advances that have been made in the last decade for treating rare diseases that affect children. However, the…

Continue Reading Study Assesses Rare Disease Treatments for Children From 2010-2018
ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
source: pixabay.com

ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients

According to a story from Financial Buzz, the precision oncology company Notable has recently announced that it has opened enrollment for a new observational clinical trial that will focus on…

Continue Reading ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
source: pixabay.com

A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling

The Platform Notable's automated technology platform was created to help predict which patients would respond better to which therapies. As no patient is the same, this study is paramount. Notable…

Continue Reading A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling

Donors are Needed Due To A Shortage of Platelets That Threatens A Young Child’s Life

Tahnee Hamilton was recently interviewed by KSL-TV about her young child, Avery, who was diagnosed less than a year ago with T Cell Acute Lymphoblastic Leukemia. About Veno-Occlusive disease (VOD) Avery…

Continue Reading Donors are Needed Due To A Shortage of Platelets That Threatens A Young Child’s Life

Pediatric Cancer and the 70th Anniversary of the Leukemia & Lymphoma Society

  When the Leukemia & Lymphoma Society (LLS) was founded in 1949 by a family in memory of their sixteen-year-old son, cancer was considered a hopeless condition. As noted recently…

Continue Reading Pediatric Cancer and the 70th Anniversary of the Leukemia & Lymphoma Society
Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies
DarkoStojanovic / Pixabay

Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies

According to a story from statnews.com, new, groundbreaking forms of treatment, such as gene therapy and CAR-T cell therapy, are giving patients with rare genetic disorders and advanced cancers more…

Continue Reading Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies
For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid
vitalworks / Pixabay

For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid

According to a story from mirror.co.uk, Jack Ruddock, aged four, had always been an endearing and good spirited child, but his life took a dramatic turn when he was hospitalized…

Continue Reading For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid

Acute Lymphoblastic Leukemia: Miracles for Millions and the People Who Created Them

  According to a recent article in MedicalXpress, the story begins fifty years ago with the grim statistics that a child with acute lymphoblastic leukemia (ALL) would not survive longer than…

Continue Reading Acute Lymphoblastic Leukemia: Miracles for Millions and the People Who Created Them

FDA Grants Orphan Drug Designation to Experimental Acute Lymphoblastic Leukemia Drug

According to a press release from British biopharmaceutical manufacturer Autolus Therapeutics, the American Food and Drug Administration (FDA) has granted the Company's experimental acute lymphoblastic leukemia (ALL) cell-based immunotherapy treatment…

Continue Reading FDA Grants Orphan Drug Designation to Experimental Acute Lymphoblastic Leukemia Drug
Sprycel Approved by FDA for Pediatric Ph+ Acute Lymphoblastic Leukemia Patients
Source: Pixabay

Sprycel Approved by FDA for Pediatric Ph+ Acute Lymphoblastic Leukemia Patients

Thanks to a Phase 2 trial, pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Ph+ ALL, now have a new treatment option. The FDA has announced approval of Sprycel…

Continue Reading Sprycel Approved by FDA for Pediatric Ph+ Acute Lymphoblastic Leukemia Patients
The Latest in St. Jude Research on Blood Cancers and Blood Disorders
qimono / Pixabay

The Latest in St. Jude Research on Blood Cancers and Blood Disorders

According to a story from EurekAlert!, the 60th Annual Meeting of the American Society of Hematology featured a number of different presentations of the latest research from St. Jude Children's…

Continue Reading The Latest in St. Jude Research on Blood Cancers and Blood Disorders
Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
Source: Pixabay.com

Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease

According to a story from the biotechnology company Amgen, a review from the European Medicines Agency (EMA) has recommended that the indication for blinatumomab, marketed as BLINCYTO®, be expanded. The…

Continue Reading Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
allinonemovie / Pixabay

Rare Blood Cancer Trial Data to be Presented in Upcoming Conference

According to a story from investors.amgen.com, the drug developer Amgen recently announced its intent to present all new clinical trial data which will feature its latest work in testing a…

Continue Reading Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia
Alexas_Fotos / Pixabay

Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia

According to a story from finanznachrichten.de, the Korean biopharmaceutical company Biocure Technology, Inc., recently announced the results of a pre-clinical trial that tested CAR-T cell therapy as a treatment for acute…

Continue Reading Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia
Study Highlights The Need For Precision in CAR-T Cell Therapies
allinonemovie / Pixabay

Study Highlights The Need For Precision in CAR-T Cell Therapies

According to a story from MedCity News, a recent study revealed a potential weakness of CAR-T cell immunotherapies that reveals the need for precision and caution in the extraction process.…

Continue Reading Study Highlights The Need For Precision in CAR-T Cell Therapies
Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS
12019 / Pixabay

Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS

According to a story from BioPortfolio, the immunotherapy drug Kymriah, a type of CAR-T cell therapy, will be funded by NHS England for the treatment of patients with acute lymphoblastic…

Continue Reading Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS
New CRISPR Study Suggests Dietary Supplement Could Enhance the Effectiveness of Chemotherapy
Source: Pixabay.com

New CRISPR Study Suggests Dietary Supplement Could Enhance the Effectiveness of Chemotherapy

There’s good news coming out of MIT this week. In an article on Medical Xpress, new findings are coming out using CRISPR, a tool that is known for its ability…

Continue Reading New CRISPR Study Suggests Dietary Supplement Could Enhance the Effectiveness of Chemotherapy
Close Menu